This site uses cookies to improve your experience and to provide services and advertising. By continuing to browse, you agree to the use of cookies described in our Cookies Policy. You may change your settings at any time but this may impact on the functionality of the site. To learn more see our Cookies Policy.
Dublin: 5 °C Monday 24 February, 2020

TCD research could lead to new treatment for asthma, dermatitis

Study has found new cells which contribute to the exacerbation of allergic diseases.

File photo of an asthma sufferer using an inhaler.
File photo of an asthma sufferer using an inhaler.
Image: Clive Gee/PA

RESEARCH WORK carried out in collaboration by scientists at Trinity College in Dublin and at Cambridge, England has the potential to be used in new methods of treating asthma, atopic dermatitis and other allergic diseases.

The research published in Nature Immunology identified new processes which lead to the development of a novel cell which contribute to allergies. The report’s authors say that they discovered distinct and previously-unknown nuocytes (which contribute to the exacerbation of asthma) arising in bone marrow.

The work was performed by Prof Padraig Fallon, Science Foundation Ireland Stokes Professor of Translational Immunology at TCD, and Dr Andrew McKenzie of the Medical Research Council Laboratory for Molecular Biology in Cambridge.

The researchers say that their findings identify targets for allergic diseases which could be developed into treatments.

  • Share on Facebook
  • Email this article

Read next: